Four steps, one hospital visit: a structured clinical assessment, a single blood draw, AI-powered analysis, and a personalised plan you can act on. Here is exactly what happens at each stage.
You do not fill out a long questionnaire yourself. A trained hospital health professional conducts a structured interview and enters your information directly into the Geneprint platform, covering the following areas.
Age, sex at birth, ancestry, height and weight (BMI), blood pressure, and country of residence.
Illnesses, chronic conditions, surgical history, previous biopsies, polyps or abnormal pathology and imaging, precancerous conditions, radiation exposure, and current medications.
A structured three-generation history: cancer type, affected relative, maternal or paternal branch, age at diagnosis, and any multiple, bilateral or rare cancers, plus known familial genetic findings.
Mammography, breast MRI, cervical and HPV testing, colonoscopy, stool-based colorectal testing, lung, prostate, dermatological and liver screening where appropriate.
Relevant reproductive and hormonal factors that influence certain cancer risk profiles, recorded where applicable.
Smoking, alcohol use, physical activity, diet, UV exposure, and occupational or environmental exposures.
Where they exist, the hospital gathers your previous screening, pathology and imaging reports, prior lab results, specialist letters, and any genetic reports already on file.
The quality of the AI output depends heavily on the quality and completeness of the clinical information gathered here. Family history in particular remains important even when whole-genome sequencing is performed.
Geneprint does not require several separate visits or draws. A single venipuncture, performed at the same appointment as your clinical assessment, fills the tubes needed for every analysis below.
Performed once. Supports hereditary variant analysis, medically actionable findings, selected polygenic risk, and pharmacogenomic insights — with future reinterpretation as evidence evolves, without resequencing.
CBC, liver and kidney function, glucose, HbA1c, lipids, and selected inflammatory and nutritional markers — health and metabolic context, not a standalone cancer screen.
Broad circulating protein patterns tied to immunity, inflammation, metabolic health and tissue activity — used to refine risk and add biological context, not as standalone diagnostic evidence at launch.
Reflects energy, lipid and glucose metabolism and nutritional state. Because it is sensitive to recent food intake, exercise, medication and acute illness, collection conditions are recorded with the sample.
Geneprint's AI integrates your genomic variants, polygenic risk, age, sex and ancestry, family history, medical history, screening results, hormonal and reproductive factors, lifestyle, and blood-based biomarkers, proteomics and metabolomics into one view of your risk.
Every prediction Geneprint returns shows the cancer type, risk category, contributing factors, confidence, and limitations — together with the next action it connects to. Geneprint should never issue an unexplained AI score.
AI supports clinical judgement. It never replaces it — a physician reviews every significant finding before your report is released.
Your assessment, blood analysis and AI review are combined into a single, integrated plan — reviewed by a clinician before it reaches you.